And theres been a lot of elegant studies done in pre-clinical models like mice where you give them, you know, sulforaphane
This is important because the deeper layers are where they can have the most impact and make the most significant difference
Neeraj Sharma, managing director and CEO of OneSource Specialty Pharma, told the Business Standard last month that demand for GLP-1 drugs such as semaglutide is exposing capacity gaps for Indias contract development and manufacturing organizations (CDMOs) across peptide APIs, sterile fill-finish facilities, injector devices, and glass cartridges
Follow-up Repeat metabolic markers after 4-12 weeks, with closer review during dose escalation or major appetite changes
Some patients also experience temporary nausea or constipation during dose increases, but these effects usually fade within a few days to a week